Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Journal Article
Number of items: 4.

Journal Article

Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp ORCID: 0000-0002-8279-7636, Rinaldetti, Sebastien, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Sikic, Danijel, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt and Otto, Wolfgang (2019). FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer. BJU Int., 123 (1). S. 187 - 197. HOBOKEN: WILEY. ISSN 1464-410X

Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp ORCID: 0000-0002-8279-7636, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Bertz, Simone, Sikic, Danijel, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt and Otto, Wolfgang (2018). High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma. Clin. Genitourin. Cancer, 16 (4). S. 248 - 259. DALLAS: CIG MEDIA GROUP, LP. ISSN 1938-0682

Eckstein, Markus, Wirtz, Ralph Markus, Gross-Weege, Matthias, Breyer, Johannes, Otto, Wolfgang, Stoehr, Robert, Sikic, Danijel, Keck, Bastian, Eidt, Sebastian, Burger, Maximilian, Bolenz, Christian, Nitschke, Katja, Porubsky, Stefan ORCID: 0000-0002-7647-7265, Hartmann, Arndt and Erben, Philipp ORCID: 0000-0002-8279-7636 (2018). mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants. Int. J. Mol. Sci., 19 (11). BASEL: MDPI. ISSN 1422-0067

Kluemper, Niklas, Ralser, Damian J., Zarbl, Romina, Schlack, Katrin, Schrader, Andres Jan, Rehlinghaus, Marc, Hoffmann, Michele J., Niegisch, Guenter, Uhlig, Annemarie, Trojan, Lutz, Steinestel, Julie, Steinestel, Konrad, Wirtz, Ralph M., Sikic, Danijel, Eckstein, Markus, Kristiansen, Glen, Toma, Marieta, Hoelzel, Michael, Ritter, Manuel, Strieth, Sebastian, Ellinger, Joerg and Dietrich, Dimo (2021). CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma. J. Immunother. Cancer, 9 (8). LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

This list was generated on Sun Nov 24 05:29:09 2024 CET.